Physical activity study for people with congenital long QT syndrome
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at how physical activity and exercise capacity affect people with a heart rhythm condition called congenital long QT syndrome. It may help you understand safe ways to stay active and improve your heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with congenital long QT syndrome
- You are able to walk and do not have severe mobility issues
- You have not had an ICD shock or fainting episode in the past 6 months
- You are willing to answer questionnaires
- You consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether wearable devices can help monitor Long QT Syndrome, a heart condition. It aims to make tracking your heart easier and more convenient than clinic visits.
This trial is a “clinical cohort” study, meaning it follows adults with certain heart rhythm issues to understand them better. Your participation may help researchers learn what to expect and how best to support people over time.
This study tests a new medicine called THRV-1268 to see if it can safely improve heart rhythm in people with Long QT syndrome types 2 and 3. It may help reduce the risk of dangerous heart rhythm problems.
This study looks at how the heart's electrical signals can help doctors understand if treatments prevent dangerous heart rhythms in active people. It involves people with or without heart devices like ICDs or pacemakers, and may help improve care for active individuals with heart conditions.
This study looks at how teens and young adults with moderate to complex congenital heart disease can improve their physical activity. You might be eligible if you're between 15 and 25, have a heart condition, and get care at Nationwide Children's Hospital or Ohio State University.
This study uses your blood or genetic information to make “iPS cells,” lab-grown cells that can help researchers study inherited heart rhythm problems like LQTS, Brugada syndrome, CPVT, or early repolarization syndrome. It may help improve understanding of why these rhythms happen and guide future treatments.
Hear when a new Long QT Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.